Login

Maxime Séché is the Chief Executive Officer of Séché Environnement, a leading environmental services company. 00:10:00

Share On Facebook Share On Twitter

Joël Séché, Président Fondateur de Séché Environnement.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Surefire Resources' Victory Bore Vanadium Project: A World-Class Asset with Significant Potential
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
Tribeca Resources Focuses on Major IOCG Deposits in Northern Chile
00:10:00
Andreas Gerward Discusses Stayble Therapeutics' Breakthrough Product STA363, Market Scope, and Capital Strategy | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
Navigating the Intersection of Politics and Medicine: Insights from a Health Ministry Veteran | Mr. Chi-Hsien Chan, CEO, Adimmune Corp .
00:10:00
Market Insights with Calamos CEO John Koudounis on CNBC
00:10:00
Lundin Gold at One-to-One Conference: Financing Success and Future Plans for the Fruta del Norte Project
00:10:00
Meet the Manager: Insights with Xuesong Zhao, Lead Portfolio Manager at Polar Capital Automation & AI Fund
00:10:00
The Secret Weapon of Startups: Global Resources & Experienced Teams|Bernard Moon,Co-Founder and Partner,SparkLabs Taipei
00:10:00
Embodied Expressions: Art Reflecting Brazil's Political and Social Turmoil
00:10:00
CHS has been developing and operating healthcare delivery systems committed to helping people get well and live healthier|Tim L. Hingtgen, Chief Executive Officer,Community Health Systems
00:10:00
Third Quarter Market Shares Breakdown and Year-End Outlook | Morgan Christen, CEO, Spinnaker Investment Group, LLC.

© 2017 - Neuhu+